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ABSTRAK 
Kaedah penggunaan analgesi/ubat penahan sakit kawalan pesakit (AKP) telah 
dilaksanakan semenjak 30 tahun dahulu lagi sebagai satu kaedah altematif untuk 
mengawal selia penggunaan analgesi/ubat penahan sakit selepas pembedahan. 
Ianya membolehkan pesakit mengawal sendiri sejumlah kecil opiod yang diperlukan 
dengan lebih baik dan berkesan. 
J umlah ubat yang diberikan kepada pesakit telah dihadkan berdasarkan beberapa faktor 
antaranya; jumlah permintaan terhadap dos, had masa kekunci dan jeda masa kekunci 
misalnya setiap jam atau setiap 4 jam . 
Kajian ini dijalankan secara rawak untuk mengkaji kesan penggunaan diantara 
campuran morfin dan alfentanil dengan hanya penggunaan morfin, keatas pesakit yang 
menjalani pembedahan 'Caesarean'. 
Selepas pembedahan, pesakit-pesakit yang telah dipilih secara rawak dan diberi 
analgesi/ubat penahan sakit iaitu campuran 0. 75 mg morfin dan 0.125 mg alfentanil 
(Kumpulan MA ditnana jumlah pesakit adalah seramai 40 orang ) atau 1.5 tng morfin 
(Kumpulan M juga dengan j umlah bilangan pesakit seramai 40 ) dengan had masa 
kekunci 8 minit dan tanpa had dos- masa atau infusi dasar. 
Pemerhatian secara klinikal dibuat pada 24 jam pertama dan pesakit dikehendaki 
tnenjawab soalan soal -selidik yang telah disediakan. 
Terdapat perbezaan yang ketara bagi penggunaan analgesi/ubat penahan sakit kawalan 
pesakit(AKP) oleh kedua-dua kumpulan dengan purata AKP yang diterima oleh 
Kumpulan MA adalah lebih besar (41.0) berbanding dengan Kumpulan M (27.4) tetapi 
skala visual analog bagi sakit yang diukur pada 2 jam, 4 jam, 6 jam dan 24 jam di dapati 
tiada perbezaan langsung. lnsiden kesan sampingan dari penggunaan kedua-dua ubat 
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tersebut adalah rendah. Tiada perbezaan ketara wujud di dalam jawapan yang diberikan 
oleh pesakit dalam borang soal selidik yang menilai kecepatan, keberkesanan dan 
jangkamasa analgesi dan secara keseluruhan kesemua pesakit sangat berpuas hati. 
Penambahan alfentanil kepada morfm tidak memberi faedah untuk penggunaan 
analgesi/ubat penahan sakit kawalan pesakit. 
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ABSTRACT 
Patient-controlled analgesia (PCA) has been used for the past 30 years as an alternative 
method to administer postoperative analgesia. Patient-Controlled Analgesia allows 
patients to self-administer small boluses of opioids, providing better dose titration and 
regulation. The quantity of analgesic available to the patient is limited by the prescribed 
patient-controlled analgesia variables; demand dose size, lockout period and hourly or 
4-hourly limits. 
In a randomized, double-blind study, I compared a combination of morphine and 
alfentanil with morphine alone for patient-controlled analgesia after Caesarean section 
under spinal anesthesia. After surgery, patients were randomly allocated to receive 
patient-controlled analgesia with a bolus dose of either morphine 0.75 mg plus 
alfentanil 0.125 mg (Group MA, n= 40) or morphine 1.5 mg alone (Group M, n=40) 
with a lockout interval of 8 minute and no hourly dose limit or basal infusion. Clinical 
assessments were made in the first 24 hours, after which patients completed a written 
questionnaire. There was a significance difference between groups in patient-controlled 
analgesia usage with the mean of patient-controlled analgesia boluses received by group 
MA bigger (41.0) as compared to group M (27.4) but the visual analogue scale scores of 
pain measured at 2, 4, 6 and 24h were not significant. 
There was a low incidence of side-effects in both groups. In the questionnaires, there 
were no differences in grading for speed of onset, effectiveness of analgesia, duration of 
analgesia and overall patient satisfaction. Addition of alfentanil to morphine does not 
have any advantages for patient-controlled analgesia. 
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1. INTRODUCTION 
Despite constantly increasing understanding of pain mechanisms and improved 
technology in pain therapy for the anaesthetist, the provision of adequate postoperative 
pain relief is still a challenge. Unfortunately, postoperative pain relief, which is 
conventionally provided by parenteral medication, is often incomplete (Keeri-Szanto 
and Heaman 1972; Tammisto 1978; Tammisto and Tigerstedt 1982; Ready 1999). As 
far as we know, conventional prescription of opioids-to be given by nurses 'as 
required'-seldom produces an adequate level of analgesia In addition, it is impossible 
to accurately predict what analgesic dosage will be required to provide sufficient pain 
relief or how much pain a patient will experience after an operation. Adequate pain 
control may even improve recovery from surgery by reducing stress and improving 
pulmonary function (Craig 1981; Bonica 1987; Kehlet 1989, 1994; Scott and Kehlet 
1988). Optimal postoperative analgesia may also reduce postoperative complications 
and shorten postoperative recovery (Kehlet 1994; de Leon-Casasola et a/. 1994). 
Patient-Controlled Analgesia (PCA) has become an established technique for the 
treatment of postoperative pain (Sechzer 1968; Scott 1970; Keeri-Szanto 1971; 
Tammisto 1978; Ready 1990; Zimmermann and Stewart 1993; Lehmann 1995). It has 
been shown to offer a number of advantages, including good analgesia, avoidance of 
fluctuations in analgesia, lower total analgesic dosage, and improved patient 
satisfaction. This method allows self-administration of small, frequent doses of 
analgesics to maintain a state of constant pain control. The effectiveness and safety of 
patient controlled-analgesia with a number of opioids have already been demonstrated 
(Lehmann 1995; Ready 2000); however, the optimal opioid has not yet been found. The 
most popular opioid in patient controlled-analgesia has been morphine (White 1988; 
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Stanley et a!. 1996), but also most other opioids have been tested (Lehmann 1995). 
Ideally, the analgesic for patient controlled-analgesia should have a rapid onset of 
analgesic action, be highly efficacious in relieving pain, have an intermediate duration 
of action (30-60 minutes), produce no tolerance or dependence, and have no or minimal 
side-effects or adverse drug interactions (White 1988; Etches 1999). 
The potency of a drug is affected by its ability to gain access to receptors as well 
as the ease with which it binds. The physico-chemical properties of opioids have 
important effects on their activity. The ability of a drug to diffuse through membranes to 
reach receptors depends upon its lipid solubility and the relative concentrations of its 
ionized and non-ionized forms. These properties can predict the actions of different 
opioids. 
Many different opioids have been used for patient-controlled analgesia (PCA) 
but no single drug has been found to be consistently better than morphine. However, 
morphine has the disadvantage of being a hydrophilic molecule (octanol/pH 7.4 buffer 
partition coefficient 1.4) and low un-ionized fraction (24 %); that enters the central 
nervous system slowly; thus morphine has a slow onset of action. In comparison, 
alfentanil has a much faster onset because of its greater lipid solubility (octanol/pH 7.4 
buffer partition coefficient 129) and high un-ionized fraction (89%) in plasma at 
physiological pH. Alfentanil is therefore more freely diffusible with a faster onset and 
shorter duration of action. Thus, the typical side-effects of opioids, such as nausea and 
vomiting, sedation, respiratory depression, and pruritus which may sometimes hamper 
the successful application of patient controlled-analgesia will be lessened (Noucutt and 
Morgan 1990; Lehmann 1993; Baxter 1994). 
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2. OBJECTIVES 
General: 
This study is design to test the hypothesis that the combination of morphine with 
the faster-acting opioid, alfentanil, would improve analgesia cotnpared with tnorphine 
alone when used for patient controlled-analgesia. 
Specific: 
1) To compare the potency, efficacy and side-effects of the two opioids 
in cotnbinations (tnorphine and alfentanil) and morphine alone. 
2) To evaluate the safety of and patient satisfaction with intravenous patient-
controlled analgesia. 
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3. METHODOLOGY 
After obtaining approval from the University Clinical Research Ethics 
Committee, I recruited, randotnized and double-blinded 80 ASA physical status I and II 
women undergoing Caesarean section. The study was conducted at Hospital University 
Sains Malaysia and Hospital Kota Bharu from September 1999 till October 2000. 
Sample size was based on data from a previous study of patient controlled-analgesia 
after Caesarean section, from which I calculated that 38 patients per group would be 
required to ensure 80% power to detect a difference of 15 mm on a 100-mm visual 
analogue scale (VAS) for pain on movement, with a type 1 error probability of 0.05. All 
patients gave informed consent and were instructed on the use of the VAS and a patient 
controlled-analgesia device (Graseby 3300patient controlled-analgesia Pump, Graseby 
Medical Limited). Patients were kept nil by mouth from 12 midnight or at least 6 hours 
prior to surgery, received 150 mg ranitidine orally the night before and the morning of 
surgery and 0.3 M sodium citrate 30 mljust before transferred to the operating theatre. 
After intravenous preload of 1 000 ml lactated Ringer's solution and skin cleaned 
with antiseptic solution and skin infiltration with lignocaine 2%, a 25-G Quincke spinal 
needle was inserted at the Lumbar 2-3 or Lumbar 3- 4 vertebral interspace with the 
patient in the lateral position. Spinal anaesthesia was established using 2.2 ml 
hyperbaric bupicaine 0.5%. Intravenous ephedrine was given as required for 
hypotension. Nitrous oxide or small intravenous doses of fentanyl were given as 
required for intra-operative analgesia, at the anaesthetist's discretion. 
After surgery, patients were randomly allocated, by drawing of shuffled, coded 
envelopes, to receive post-operative analgesia by patient controlled-analgesia using one 
of two solutions: morphine 0.5 mg·mr1 plus alfentanil 0.083 mg·mr1 (group MA, n = 
5 
40) or morphine lmg·ml-1 alone (group M, n = 40). The ratio of alfentanil to morphine 
( 1 :6) was based on published data on equipotency ratios for opioids used for patient 
controlled-analgesia calculated according to pain scores and drug consumption. The 
patient controlled-analgesia solutions were prepared by a staff nurse who was instructed 
and supervised on how to prepare the solutions. The patient controlled-analgesia device 
was connected to a dedicated intravenous catheter and set to deliver a bolus dose of 1.5 
ml~ thus at each successful patient controlled-analgesia demand, patients in group MA 
received morphine 0.75 mg and alfentanil 0.125 mg, and patients in group M received 
morphine 1.5 mg. A lockout time of 8 minute was used with no dose limit over time, in 
keeping with our standard protocol. Patients were observed by the nursing staff in the 
postnatal ward according to the usual protocol for patient controlled-analgesia i.e. the 
hospital APS (Acute Pain Service) protocol, which includes hourly recording of level of 
consciousness and respiratory rate. Metoclopramide 10 mg intramuscularly was charted 
as required to treat nausea and vomiting. The on-caJl anesthetic Medical Officer was 
available to attend at all times. 
A staff nurse, who was blinded to the patient's group, assessed each patient at 2, 
4, 6 and 24 hour after surgery. At each assessment, patients were asked to grade their 
pain at rest, pain on coughing, nausea, dizziness and sleepiness using the visual 
analogue scale. At 24 hours, the total numbers of patient controlled-analgesia demands 
and boluses delivered were obtained from the electronic memory of the patient 
controlled-analgesia device. In addition, patients were given a written questionnaire to 
complete which asked their assessment of aspects of the analgesia obtained from the 
patient controlled-analgesia regimen (Appendix). Assessments were made on an 11-
point numerical scale. 
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Chi-squared tests and Student T- tests were used as appropriate to compare 
categorical data and numerical data respectively, between 2 groups. Repeated Measure 
Analysis of Variance (ANOVA) was applied to compare mean scores of visual analogue 
scale and Prince Henry scores for pain, and visual analogue scale of side-effects 
between 2 groups. Other demographic variables effects were tested if they should be 
included in the model. The significant level was set at 0.05 and 95% confidence 
intervals were applied as appropriate. 
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4. LITERATURE REVIEW 
4.1 PATIENT-CONTROLLED ANALGESIA (PCA) 
4.1.1 Principles and development of patient controlled-analgesia 
Traditional techniques for the provision of postoperative analgesia by 
intermittent intravenous or intramuscular injections of an opioid drug do not meet the 
needs of every patient. Patient-Controlled Analgesia (PCA) allows every patient to self-
administer small boluses of opioids, providing better dose titration and regulation 
(Bennett et a/. 1 982). This avoids the 'peak and valley' effects encountered with 
conventional intramuscular administration of analgesics. Stable drug plasma 
concentration is an important goal of postoperative pain management. When using 
patient controlled-analgesia, the plasma concentration at which the patient becomes 
sufficiently uncomfortable to make a dose demand has become known as the minimwn 
effective (analgesic) concentration {IvfE(A)C) (Dahlstrom et a/. 1982; Gourlay et a/. 
1988; Lehmann 1995; Woodhouse and Mather 2000). Intrapatient variation in rvffiAC 
for tnorphine in the treatment of postoperative pain has been relatively small 
(Dahlstrom et a/. 1982), but interindividual variation in the plasma concentration of 
opioid required to achieve adequate pain relief has been large (Dahlstro1n et al. 1982; 
(Jourlay et a/. 1988). As a result, self-administration of opioids after abdominal and 
orthopaedic surgery has been characterized by considerable variability in individual 
morphine consumption (Lehmann et a/. 1985). 
Patient controlled-analgesia allows patient to take direct control of 
administration of discrete doses of an analgesic agent for the relief of pain. In practice 
the patient is instructed to press a push-button whenever pain relief is required. If preset 
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time and/or dose limits are not exceeded, then activating the demand mechanism results 
in a dose of drug being administered; this may be systemically or spinally. In this way, 
patient controlled-analgesia is a simple feedback loop that does not require the 
intervention of medical or nursing staff at the time of each analgesic demand Patient 
controlled-analgesia can provide better pain relief than intermittent intramuscular 
injections or continuous infusions of opioids, but not automatically; patient controlled-
analgesia must be understood by medical and nursing staff and the patient to reach its 
full potential. 
An important advantage of patient controlled-analgesia is its ability to minimize 
the time-delay between perception of pain and administration of medication (Lut= and 
Lamer 1990). 
The frrst attempts to establish intravenous patient controlled-analgesia were 
made in the late 1960s, after patient controlled-analgesia with intermittent intravenous 
doses of narcotic analgesics was first described by Philip Sechzer (Sechzer 1968, 1971, 
1990), who reported that such a patient-controlled analgesic-demand for the alleviation 
of pain and for the reliable measurement of pain and pain relief had been under study 
since 1965. In this system, patients when they felt pain during recovery from surgery 
were instructed to press a button. When this button was pressed, a nurse observer 
administered 1 ml of pethidine- or morphine-containing solution (Sechzer 1968, 1971). 
At the same time, the concept of patient controlled-analgesia was developed 
independently in the U.K. by Scott, who permitted the patients to operate a hinge-lever 
spring clamp that restrained the intravenous drip flow of pethidine, so patients 
controlled their own intravenous infusion rate of analgesic (Scott 1970). In 1970, 
Forrest and his co-workers described a more sophisticated apparatus (Demand 
Dropmaster ), which after the patient pressed the button on a handgrip device, 
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automatically dispensed intravenous analgesic drugs on demand (Forrest et al. 1970). 
Keeri-Szanto eventually developed a commercial machine with an electrically 
controlled syringe pump (Keeri-Szanto1971). The analgesic efficacy of patient 
controlled-analgesia has been demonstrated to be superior to that obtained with 
intermittent intramuscular injections (Keeri-Szanto and Beaman 1972). After this, 
several experimental systems for the self-administration of analgesics have been 
described (Evans eta!. 1976; Tammisto 1978; Hull eta/. 1979; Hull and Sibbald 1981; 
Rosenberg et a/. 1984). With the development of microprocessors improving the 
technology of patient controlled-analgesia pumps, the clinical use of patient controlled-
analgesia became more popular and widespread (Kay 1981; Rowbotham 1992). 
Patient controlled-analgesia is an effective and safe means to provide pain relief 
for cancer patients (Citron eta/. 1986), and the technique has been proven beneficial in 
patients ranging in age from children as young as 5 years to frail, elderly men (Egbert et 
al. 1990; Irwin et al. 1992). 
In patients undergoing bone marrow transplantation and in women after 
abdominal hysterectomy, patient controlled-analgesia therapy decreases the morphine 
requirement compared to that in a continuous morphine infusion (Hill et al. 1990; 
Parker et al. 1991). 
The continuous background infusion of morphine during patient controlled-
analgesia analgesia has been studied extensively, and shown to increase morphine 
consumption, sedation, and respiratory depression without improving pain relief or 
patient satisfaction (Owen et al. 1989; Wu and Purcel/1990; Parker et al. 1991; 1992; 
Tigerstedt et a/ 1991; Russell eta/. 1993; Baxter 1994; Etches 1994). On the other 
hand, following abdominal surgery, a continuous morphine infusion of 1 tng/h with 
intravenous patient controlled-analgesia (morphine 1 mg bolus and 5 min lockout 
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period) has improved analgesia during the first 24 hours. This method was associated 
with a greater incidence of complications than with intravenous patient controlled-
analgesia alone (Dawson et a!. 1995). In the light of all this, the efficacy of combining a 
continuous infusion with intravenous patient controlled-analgesia is uncertain 
Patient-controlled analgesic administration offers the best individualization, and 
in addition, patient controlled-analgesia should be considered for those patients with the 
most resistant pain (Tammisto 1978; Tammisto and Tigerstedt 1982). 
4.2 PATIENT-CONTROLLED ANALGESIA: CAN IT BE MADE SAFER? 
Over the past thirty-five years, Patient-Controlled Analgesia (PCA) has 
developed from a research tool to become a major component in the treatment of pain. 
Originally the scope of patient controlled-analgesia was limited to intravenous therapy 
for postoperative analgesia in adults, but with its proven efficacy, its range of 
applications has grown. Patient controlled-analgesia is now used in paediatric surgery, 
obstetrics, trauma, burn's patients, those receiving immunotherapy and in a variety of 
medical conditions such as acute myocardial infarction, sickle-cell crisis and herpes 
zoster. In addition, in some areas, the intravenous route of administration has been 
replaced by oral, sublingual, subcutaneous, intramuscular and epidural patient 
controlled-analgesia. 
Most physicians and patients would still agree with Rosen's statement that ' ..... it 
is better to be in pain than killed by analgesic'. However, recent audits of current 
practice with patient controlled-analgesia both in the United States and England indicate 
that effective postoperative analgesia can usually be cotnbined with its safe 
administration. A survey from the Cleveland Clinic Foundation reviewed medication 
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mishaps in 3,299 patients who were receiving patient controlled-analgesia. There were 
42 mishaps (1.2%): 22 were operator related, 15 equipment malfunctions and five cases 
of adverse drug reaction (norpethidine toxicity in four cases and morphine overdose 
compounded by renal failure in the remaining patient). A comprehensive survey of the 
first thousands patients involved with patient controlled-analgesia in a district general 
hospital in the U.K. showed that technical problems (e.g. deprogramming and disorders 
of trigger mechanism) were more common than adverse clinical effects. Respiratory 
problems occurred in 2.5% of all patients on patient controlled-analgesia, but in less 
than half of these patients was it necessary to stop the patient controlled-analgesia 
treatment prematurely. Two factors may be responsible for the apparently low 
complication rate. First, patient controlled-analgesia machines are not available in the 
majority of hospitals: insufficient numbers of machines to cover all postoperative 
patients dictate that these are used on a preselected group who may be in general fitter, 
younger and undergoing more major surgery. Second, it is still the case that patient 
controlled-analgesia is being popularized by a relatively small group of enthusiastic 
anaesthetist who spend considerable time pre- and postoperatively in the management 
of these patients. 
There are groups of patients in whom patient controlled-analgesia may be 
unsuitable, or potentially dangerous and difficult to administer. Careful preoperative 
assessment will help to exclude these cases. Awareness of the aims and limitations of 
the treatment, for both nursing and medical staff, becomes better developed following 
comprehensive education. Similarly, patients undertaking patient controlled-analgesia 
therapy need teaching in the technique along with information regarding potential 
worries they may have about the therapy. Dramatic technological advances with patient 
controlled-analgesia equipment over the past five years have dictated the equiptnent 
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familiarization is essential for all involved in its delivery. If patient controlled-analgesia 
is to be used safely in any hospital, its introduction must have minimal impact on 
current nursing and medical routine. Moreover, potential problems and interactions 
between the different components of the patient controlled-analgesia system are 
becoming evident. Finally, clinical audit is essential to allow critical appraisal of the 
efficacy of this treatment modality along with potential adverse effects. 
4.3 PATIENT SELECTION 
For the technique to be effective, patients must be able to understand the 
mechanism of their analgesia. A painful stimulus must be assessed by the patient who 
can subsequently elicit an appropriate response, i.e. a push of the patient controlled-
analgesia button. This tnay not be possible in the very young, who are unable to make 
the connection between pain and relief; the very old, whose short term memory may 
preclude the retention of even the simplest of instructions~ and in those patients with 
acute confusional states or organic brain syndromes. 
Although most patients cope well with patient controlled-analgesia, there are 
some in whom the concept of complete control may be intimidating and where patient 
controlled-analgesia is totally unsuitable. The success, therefore, of this therapy can be 
significantly limited by the psychological make-up of the patient. The concept of 'locus 
of control' was described in the mid-sixties by Rotter and subsequently developed into a 
Multidimensional HeaJth Locus of Control (MHLC) scale that categorized patients 
depending on their attitudes to behaviour and subsequent reinforcement. Those who see 
their own actions as contributing to the reinforcement have an 'internal' locus of control 
and tend to be active in controlling their environment. These patients respond well to 
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patient controlled-analgesia and are able to use it effectively. Conversely, patients who 
have an 'external' locus of control relate positive reinforcement to other people or 
events, resulting in loss of control, strong reliance on others and failure of the technique. 
Neuroticism, anxiety state and anxiety trait are positively correlated with postoperative 
pain scores. Whether preoperative questionnaires are a practical screening procedure for 
institution of patient controlled-analgesia is under debate. Until a uniform, reproducible 
and a simple assessment is available, clinical impression and evaluation by the 
physician and nurse will be the most important aspect in patient selection. 
Patients who are intravenous drug abusers present a particularly difficult 
problem both in assessment of analgesic requirements and therapeutic effect. The 
analgesic end-point sought by non-addicted patients is tempered by their desire to stay 
as alert as possible. Keeri-Szanto contrasted these to addicted patients who ' ... 
administered narcotics to the brink of unconsciousness, "coming up for air" only long 
enough to trigger the administration of more drugs'. Some centers allow intravenous 
(e.g. heroin), and inhalational (e.g. cocaine and 'crack') drug abusers, free access to 
their patient controlled-analgesia service. Patients suspected of seeking 'high' rather 
than analgesia, or tampering with the patient controlled-analgesia devices, have these 
withdrawn. Reliance is placed on the honesty of these patients, to comply with 
treatment. We have found patient controlled-analgesia less than ideal with these 
patients, due to their continuous drug-seeking behaviour, interference with patient 
control1ed-analgesia devices and manipulative personalities. Reliable feedback 
concerning the efficacy of the treatment cannot be differentiated from a desire to obtain 
a 'high'. The increased nursing and medical time that is involved with using patient 
controlled-analgesia in these patients must be considered, especially when it may 
interfere with the treatment of other patients and result in damage to equipment. 
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The consideration of patients for patient controlled-analgesia who are or who 
may become hypovolemic presents another difficult therapeutic dilemma. Analgesics 
agents are ideally administered to these patients in small intravenous boluses, yet 
constant assessment of neurological and cardiovascular parameters is essential, due to 
preferential distribution of blood flow to the heart and brain in such shocked individuals 
(Figure 4.1 ). Whilst the problems of erratic absorption and potential bolus 
administration following reperfusion are recognized with intramuscular injection, 
opinion is divided as to whether patient controlled-analgesia is safe in this group of 
patients. In a recent study of ours in which different sized bolus doses for patient 
controlled-analgesia were compared, two patients developed respiratory depression 
requiring naloxone administration. Both of these patients had hypovolemia secondary to 
covert blood loss. These support recommendations made by Tamsen and colleagues that 
patient who have labile cardiovascular parameters are unsuitable for patient controlled-
analgesia and contrasts with the experience of Notcutt who advocate the usefulness of 
patient controlled-analgesia in this group of patients. Caution is advised if patient 
controlled-analgesia is used in any patient with an unstable cardiovascular system. 
Careful pre- and postoperative assessment by anaesthetic and nursing staff will help to 
identify all these patient subgroups and assess their suitability for patient controlled-
analgesia accordingly. 
HYPOVOLEMIA 
~ 
REDUCED INTRA VASCULAR VOLUME 
~ 
REDISTRIBUTION OF BLOOD FLOW 
/ ' 
PREFENTIAL CEREBRAL 
BLOOD FLOW 
INCREASED EFFECT 
DRUG 
DECREASED LIVER 
BLOOD FLOW 
DECREASED CLEARANCE OF DRUG 
PROLONGED EFFECT 
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Figure 4.1. - The effects of delivery of patient controlled-analgesia bolus tn 
hypovolaemic patients. 
4.4 EDUCATION 
Comprehensive education of patients, relatives, nursing and medical staff, both 
anaesthetic and surgical, can be the most important measure to ensure safety and 
efficacy of patient controlled-analgesia. Patients can be educated by the anaesthetist at 
the preanaesthetic clinic and/or preoperative visit, and this should be reinforced by ward 
and theatre staff Patients' expectations and apprehensions need to be identified 
preoperatively before patient controlled-analgesia is instituted. A recent survey revealed 
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that the main disadvantage of patient controlled-analgesia as perceived by patients 
preoperatively was a reduction in the total time spent in contact with nursing staff. A 
smaller number worried about equipment failure, overdosage and addiction potential, 
whilst interestingly, very few saw patient controlled-analgesia as a way of totally 
relieving pain. The control of pain seemed as important as the amount of pain reduction 
experienced. 
Other workers have indicated that careful and time consuming preoperative 
education for patients intending to use patient controlled-analgesia does not influence 
their ability to adequately self-administer analgesia. Although this can be reassuring for 
those patients who have tnissed preoperative education it does not indicate it is of little 
value. There are often worries and apprehensions that will only become apparent when 
instructing patients on the use of patient controlled-analgesia. The goals and safety 
features of patient controlled-analgesia also need explanation to relatives. In some 
circumstances, e.g. parent-controlled analgesia, relatives are given formal training and 
are encouraged to assist their children in activating the patient controlled-analgesia 
device. However, this breaks the negative feedback loop, whereby excessive sedation 
prevents the administration of further amounts of opioid. It can also be broken by 
concerned partners who activate the pwnps for the patient. Obviously the consequences 
can be disastrous. Manufacturer of patient controlled-analgesia devices are now 
producing patient information sheets that attempt to explain and to answer in an 
attractive and simple way the use of patient controlled-analgesia and worries that the 
patients may have, and these also emphasize positive features of this treatment option. 
The value of this has not been studied. Work in other areas has shown that simply 
handing the patient such infonnation is not enough, and that reinforcetnent by nursing 
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and medical staff ts essential for information to be adequately and efficiently 
understood. 
Education of nursing staff is ideally carried out by a dedicated nurse educator, 
whose aims are to teach the basic principles of patient controlled-analgesia, potential 
adverse effects, evaluation of problems and intervention strategies. This need to be 
addressed in all areas where patient controlled-analgesia is being used operation theatre, 
recovery and especially ward staff need to be fully acquainted with the theoretical and 
practical components of the technique, the equipment and the monitoring. Staffing 
changes along with quality assurance programs dictate that this cannot be accomplished 
in one visit so that ongoing education is essential to ensure continuity of care and 
prevention of mishaps. 
Medical staffs, both anaesthetic and surgical, need to be fully aware of treatment 
options, equipment and its limitations, along with potential problems before prescribing 
patient controlled-analgesia. Historically the prescription and assessment of 
postoperative analgesia was under the control of the surgical team. The role of the 
anaesthetist in the postoperative period has grown in recent years in some hospital to 
include fluid balance, parenteral nutrition and now more than ever the prescription and 
delivery of analgesia. Surgeons may view this as interference if adequate information 
and communication is not presented by the anaesthetic staff. The inception of acute pain 
services has helped in providing a coordinated team approach, so that problems relating 
to patient controlled-analgesia can be collected centrally and a rapid and effective 
resolution facilitated. 
Anaesthetist who prescribes patient controlled-analgesia need to be aware of the 
variants and variables involved in its administration. Variants include bolus demand, 
infusion demand, bolus demand plus constant infusion, and bolus demand with variable 
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infusion. The variables involved are the drug itself, dose size, maximum dose and 
lockout interval. Although most variants are available with all patient controlled-
analgesia machines, the variable infusion rate was only present on one device. When 
considering variants and variables of patient controlled-analgesia, results of studies 
should not be extrapolated beyond the context of their design. Several studies have 
concluded that the addition of a background infusion of morphine to patient controlled-
analgesia fails to improve analgesic effect, despite the administration of a larger dose of 
opioid and may increase side-effects such as sedation and confusion, while other 
workers support the benefits of a background infusion to increase analgesic efficacy. In 
another study, patients tended to seek analgesia, reflected as number of boluses, at the 
same rate, irrespective of the bolus dose size, suggesting that the actual bolus size 
prescribed is not as critical as previously thought. These studies only reflect experience 
with morphine, and further work with other opioids is needed. Safe prescribing of 
patient controlled-analgesia depends on a thorough knowledge of the current patient 
controlled-analgesia literature along with sound clinical experience. 
4.5 EQUIPMENT 
Malfunction of equipment was one of the biggest worries of the pioneers of 
patient controlled-analgesia, yet the paucity of articles regarding mishaps would suggest 
that such problems are not common. Equipment used for the administration of patient 
controlled-analgesia can be considered to fall into major components, the pwnp itself, 
and the accessories (e.g. the drug reservoir, delivery tubing, anti reflux valves and 
patient push-buttons). 
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Ideal characteristics of patient controlled-analgesia pumps were suggested by 
Norman at the first International Workshop on Patient-controlled Analgesia. Experience 
with a variety of pumps over the past six years had led us to propose the optimal 
characteristics of a patient controlled-analgesia pump. These should be borne in mind 
when considering purchase of these pumps. 
4.5.1 Dual power supply 
If mains operated, a reliable and long-acting battery back-up is required, with 
memory of previous progrrun retained. Battery-only devices have the major advantage 
of portability and minimal hindrance to patients who may be ambulant. However, the 
battery life must be sufficiently long duration to allow uninterrupted use for individual 
patients, along with accurate rates of delivery at variable voltage inputs. 
4.5.2 Drug specific pumps 
These are designed for the individual agents, which negate the need to calculate 
concentrations and rates for individual drugs. Manufacturers' modifications of existing 
pumps, such as with plastic overlays that clearly identify the drug in the syringe along 
with the route of adtninistration and communicate this infonnation to the pumps' 
microprocessors, can be made. This may also help prevent the potential problem of 
attaching an intravenous line to an epidural or ad.Ininistering a drug destined for a vein 
into the epidural space. This has occurred with cephazolin, thiopentone, diazepam, 
potassium chloride and total parenteral nutrition with variable neurological sequelae. 
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4.5.3 Programming 
The program should be simple to run, with no more than two steps needed to 
initiate any particular variable change. Menus should be easily read, illuminated for the 
night-time use, along with clearly labeled prompts on the screen. Once programmed, the 
tnachine should scroll the completed patient controlled-analgesia prescription for review 
before starting the infusion. Limits need to be set for maximum drug concentration, 
infusion rate, bolus rate and lockout interval. Alternatively, these can be inbuilt, and 
will be specific for each particular drug. Software protection against current surges and 
static interference is essential, not only to provide protection for the pwnp but also to 
prevent reprogramming and inactivation of alarms. The Graseby patient controlled-
analgesia recently underwent a voluntary recall following the unprogrammed infusion 
of drug into a patient resulting from an electrostatic disturbance (ESD) associated with 
reconnection of power cord. Software 1nodifications along with protection against 
electrostatic disturbance (ESD) may help prevent such problems in the future. One 
patient controlled-analgesia pump under development (by Bard) will have 
interchangeable preprogrammed 'chips' inserted into the pumps, so not only can the 
pump be dedicated to a particular drug, but a customized prescription for different 
modes of delivery and patient requirements can be used, thus removing yet another 
potential source of error, the setting-up of the patient controlled-analgesia prescription. 
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4.5.4 Activation buttons 
The patient-machine interface needs consideration so that a continued pressure 
does not lead to persistent drug delivery and overdose. Ideally, activation of the pump 
should be initiated by a double button push or release of a cover on the activation button 
to prevent the accidental initiation of a bolus. By acting as a reaction-tiine tester, it may 
reduce the chance of a confused or sedated patient inappropriately demanding another 
dose. Fears that patients may not be able to carry out this more complicated activation 
process have not been confirmed in clinical practice. 
4.5.5 Alarms 
These should be of two types, relating to the significance of the problem and 
should combined audible and visible components~ e.g. a quite, low-pitched alarm to 
warn against low battery, and a louder high-pitched alarm to warn air in line, line 
occlusion or empty syringe is advantageous. The patient should not be able to interfere 
with or silence these alarms. 
4.5.6 Physical characteristics 
Pumps need to be lightweight, robust and able to tolerate minor trauma, while 
their action should be silent to minitnize disturbance to patients and those around thetn. 
Accuracy of the pump should be within 10% of set values. The high internal resistance 
of patient controlled-analgesia pumps cotnbined with the use of high-volume syringes 
necessitates these devices generating high driving pressures. It is important that in 
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combination with epidural catheters and filters, the delivery characteristics is not altered 
and that occlusion alarms are not continually activated by the high line pressures that 
are generated. 
4.5. 7 Security 
To avoid 'tampering' by untrained staff or patients it is mandatory that the 
analgesic reservoir cannot be detached from the pump during use. As most solutions are 
dilute, and due to the increasing use of epidural opioids, drug volumes required for 
patient controlled-analgesia devices are often large. This requires the frequent changing 
of syringes. As most medication mishaps are due to errors in making up solutions and 
initiating treatment, a large reservoir would be beneficial in reducing changeovers. This 
is present in the Abbott Pancretec Provider 5500 patient controlled-analgesia, Bard 
Ambulatory pwnp and Phannacia 5800 patient controlled-analgesia device, which can 
house reservoirs containing hundreds of millimeters in a portable sealed case. 
Some pumps (e.g. models in the Abbott Lifecare series and a version of the 
MDS I 10 patient controlled-analgesia) have used dedicated prefilled syringes that can 
be replaced as necessary. Thomas and Owen reported a case of respiratory depression 
caused by a crack in a glass syringe leading to siphoning of a significant dose of 
morphine into a patient. Two factors combined to produce this complication; the 
presence of the crack allowed air to gain entry into the system whilst the adhesive label 
held the broken cartridge together thus simultaneously preventing the loss of drug. The 
siphoning effect was compounded, the pump being placed at a higher level than the 
patient. 
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Intravenous patient controlled-analgesia is commonly administered into the 
same cannula as the maintenance fluid. The importance of using anti-reflux valves in 
this situation has been reviewed in detail elsewhere. They are of value in preventing the 
retrograde flow of analgesic in the parallel line following an occlusion. Once the 
obstruction is released, a potentially dangerous bolus may be suddenly presented to the 
patient. The characteristics of the ideal anti-reflux valve are shown in Table 4.1. 
Table 4.1-Characteristics of the 'ideal' anti-reflux valve 
1. Low stored volume. 
2. No retardation of fluid flow. 
3. Incorrect orientation impossible. 
4. Integral part of administration set. 
5. Cheap. 
Large bore tubing is needed to prevent retardation of fluid flow if resuscitation 
is required. Valves and tubing of low compliance prevent the occurrence of a large 
stored volume of analgesic that may occur if a pump continues to work against an 
obstruction. This may be subsequently delivered as a bolus to the patient. Thus careful 
matching of pwnps to delivery systems and drug dilutions is of great importance. The 
potential bolus delivery from one pump and delivery system following release of an 
occlusion could be up to the equivalent of 6mg of morphine, whilst from another pump 
using the same system the bolus may only approximate to 2 mg. The compliance of the 
system affects not only the stored volume characteristics but also detection of occlusion 
alanns. 
For instance the Provider 5500 system has very low compliance so that 
occlusions are detected rapidly, but this can be defeated if it is then attached to a 
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compliant extension tube which will result in a longer time to detect an occlusion, a 
large stored volume and therapeutic failure. As with any valve it is important that the 
direction of permitted flow cannot be altered by the patient or untrained staff One 
version of the Cardiff valve which changed the direction of flow by rotation of an 
external tap had this potential problem. Fluid administration sets with an integral anti-
reflux valve, used in conjunction with dilute analgesic from the patient controlled-
analgesia device, may prove to be the safest and best; e.g. TUT A giving set (Lane Cove, 
N.S.W.). Finally the characteristics of the administration set with respect to the potential 
for siphoning have important consequences if not appreciated. The Provider 5500 
patient controlled-analgesia pump, which has a dedicated cartridge for administration, 
can allow fluid to flow freely intravenously when disconnected from the pump. This 
only occurs with the intravenous mode of patient controlled-analgesia and is 
compounded when the pump is placed higher than the patient. This potential problem 
was highlighted by a recent ECRI (Emergency Care and Research Institute) report (vide 
infra) which advocated the use of gate clips when changing cartridges or syringes. 
4.6 MONITORING 
4.6.1 Equipment 
Careful monitoring will prevent the advent of most mishaps with patient 
controlled-analgesia. The patient needs monitoring for side-effects and efficacy of 
treatment, as do the pwnp and delivery system. This can be carried out at several levels 
in order to optimize safety. 
Biomedical engineers, along with anaesthetic technicians, have an important role in pre-
installation tests and quality control. All pumps should be bench-tested and should 
